This bsApt also induced an immune response (infiltration of CD3+ lymphocytes at tumor with increased expression of IFNγ, TNFα, and IL-10) and potentiated a combination of GVAX and transient Foxp3 blockade via the P60 peptide (resulting in decreased tumor size and increase survival) in vivo. Here, FOXP3 is linked to neoplasm.